Biosurgical Agents – Market Insights – Latin America (Supplemental)
The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable demographics in the region, heightened awareness of their clinical benefits across diverse procedures and their expanding indications for biosurgical agents.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the Latin American region from 2019 through 2033.